Andrew Barkmeier MD (@AndrewBarkmeier) header
Andrew Barkmeier MD (@AndrewBarkmeier) profile picture

Ophthalmologist & Vitreoretinal Surgeon @MayoClinicEye @MayoClinic

Joined November 2015
Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)
🤷🏼‍♂️Any difference between intravitreal antiVEGF meds in risk of systemic SAEs? We report real world data on 87,844 pts starting antiVEGF💉👁 👩🏻‍⚕️: NO difference in risk of 💔,🧠,🩸, or 🏥 after bevacizumab, ranibizumab, or aflibercept Check it out! #retina
Large database study showed no difference in the rate of cerebrovascular disease, myocardial infarction, major bleeding, or hospitalization following intravitreal injections of bevacizumab, ranibizumab, or aflibercept for retinal conditions ow.ly/nm2d50AYSWT
4
12
2
64
Andrew Barkmeier MD retweeted
THE WORLD SERIES CHAMPIONSHIP BELONGS TO MILWAUKEE, WISCONSIN!!!!!!!!!!!!!!!!!!!!!!!
2,004
20,026
2,995
78,505
6,741,032
Andrew Barkmeier MD retweeted
FOR THE FIRST TIME EVER
141
2,503
98
21,963
252,713
Andrew Barkmeier MD retweeted
WORLD SERIES CHAMPIONS. Congratulations, @Brewers!
48
945
15
7,226
81,345
NAION is rare. Whether GLP-1 medications cause it remains uncertain. For patients who need these medications for diabetes, heart disease, or severe obesity, the benefits likely outweigh the possible risk. Don't stop your medication without talking to your doctor, and if you have sudden, painless vision loss in one eye, see an ophthalmologist promptly. Read the full statement: aao.info/4AqAz05 #AAO #GLP1 #EyeHealth #Ophthalmology @NANOSTweets
3
16
4
30
6,805
Andrew Barkmeier MD retweeted
Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study ow.ly/O5sb50Z7cwC #ophthalmology
4
1
4
1,530
Andrew Barkmeier MD retweeted
The June issue of Ophthalmology Science is out now! Featuring articles on: ✅Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Protocol AN) ✅Volumetric analysis of perimetry tests to guide central testing: the functional vulnerability zone ✅Who Gets Panretinal Photocoagulation? National Patterns in Proliferative Diabetic Retinopathy Treatment ✅Cystoid Macular Edema in Retinitis Pigmentosa: Pathophysiologic Insight Using Swept-Source Optical Coherence Tomography and Angiography And much more! ophthalmologyscience.org/iss… #ophthalmology
1
3
9
812
Andrew Barkmeier MD retweeted
Proliferative Diabetic Retinopathy Incidence and Outcomes in Younger Patients from 1970-2019 ow.ly/UomK50Z4jQ9 @andrewbarkmeier #ophthalmology #retina
1
6
9
764
Andrew Barkmeier MD retweeted
GLP-1 receptor agonists and the retina What to watch for and how to manage any issues that occur: retina-specialist.com/articl… #retina #retinaspecialist #ophthalmology #ophthalmologist #eyecare #glp1
1
6
130
Andrew Barkmeier MD retweeted
What does current data tell us about GLP-1 receptor agonists and diabetic retinopathy? 💉 Here's what eye doctors need to know: retina-specialist.com/articl…🔗 #retina #retinaspecialist #ophthalmology #glp1 #semaglutide #ozempic #glp1s #diabeticretinopathy #retinopathy
5
7
213
DRCR Retina Network @DrcrNet is certifying new clinical trial sites and enrolling patients for two important RCTs with surgical treatment arms: Protocol AM for symptomatic ERM Protocol AP for moderate PDR Reach out to: [email protected] to get involved!
Are you interested in DRCR research? Andrew J. Barkmeier, MD, shared information on Protocols AM and AP, and how to get involved. @YoungMDConnect @VitBuckleSoc #VBSinWonderland #retina
165
Join us for Eyes on GLP-1: Impact on Ocular Health — a live ADA member-exclusive webinar exploring the link between GLP-1 therapies and ocular outcomes. 📅 Mar 25 | 12–1 PM ET Register: bit.ly/4bNiEWV #WeFight @AndrewBarkmeier
1
381
Join us for Eyes on GLP-1: Impact on Ocular Health — a live ADA member-exclusive webinar exploring the link between GLP-1 therapies and ocular outcomes. 📅 Mar 25 | 12–1 PM ET Register: bit.ly/4bNiEWV #WeFight @AndrewBarkmeier
1
230
Yes, recommend eye protection👍 We’re seeing an increasing number of vision-threatening pickleball eye injuries
A couple of important lessons to be learned here… 1) There’s zero reason to full-send a popup at your opponent when he’s down on the ground. That ball could have been put away a hundred different ways rather than hitting it as hard as you can directly at the guy. 2) This is a perfect example of why eye protection matters. At the very least wear a forwards hat to give your eyes some protection. The kid thankfully walked away with no serious damage, dabbed it up, and showed good sportsmanship. This could have ended very badly. 😬
3
88
Andrew Barkmeier MD retweeted
We are very pleased to announce Dr. Matthew Starr as @mayocliniceye #Ophthalmology Residency Director. Thank you for continuing our program’s legacy of educational excellence!
2
4
32
893
Andrew Barkmeier MD retweeted
Ophthalmology notes are full of acronyms - “CME, PPV, NAION." In our @MayoClinic randomized QI study, we added plain language summaries and tested them in real care settings. 85% of non-eye clinicians preferred Opthalmology notes with an AI-generated summary. #MedTwitter #AI #LLM
Integrating large language model-generated plain language summaries into ophthalmology notes can improve interdisciplinary communication, although ongoing review and safety monitoring are necessary for successful clinical implementation. ja.ma/4jdUq94
1
1
8
432
Andrew Barkmeier MD retweeted
This retrospective study suggests a modestly increased risk of nonarteritic anterior ischemic optic neuropathy (NAION) in patients with type 2 diabetes using semaglutide. ja.ma/4k9o2Gc
6
2
15
2,584
Andrew Barkmeier MD retweeted
Tonight I gave my final presentation on the ⁦referendum for Rochester schools and here’s a short final video that I hope you’ll watch and share. We have done all we can to explain what’s at stake, and now it’s time for the people of Rochester to decide. youtu.be/b7edFAoSosU
1
6
22
1,180